French biotech stock soars 30% after new data on experimental medicine
">
French biotech stock soars 30% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
This article was created based on information from various sources and rewritten for clarity and originality.
